THE CAT SCRATCH DISEASE. / LA ENFERMEDAD POR ARAÑAZO DE GATO. - DERMAGIC EXPRESS / Dermatologia y Bibliografia - Dermatology & bibliography DERMAGIC EXPRESS / Dermatologia y Bibliografia - Dermatology & bibliography: THE CAT SCRATCH DISEASE. / LA ENFERMEDAD POR ARAÑAZO DE GATO.

domingo, 24 de noviembre de 2024

THE CAT SCRATCH DISEASE. / LA ENFERMEDAD POR ARAÑAZO DE GATO.


The Cat Scratch Disease. !!


La enfermedad por arañazo de gato. !!

 

The Cat scratch disease

ACTUALIZADO 2017 - 2024 

   EDITORIAL ENGLISH
===================

Hello friends of the network. DERMAGIC EXPRESS Again with a very interesting topic about pets, in this case the cute kittens. Today's topic THE CAT SCRATCH DISEASE (SCD) Transmitted Zoonotic Disease by the bite or scratches of our pets, cute kittens.

The causal agent of this disease is the Bacteria Bartonella Henselae, according to the scientists more than half of the cats are carriers of the same. The bacterium is transmitted from cat to cat by cat flea Ctenocephalides felis.

 The disease begins as a papule at the site of inoculation. Which is transformed into pustule and later a regional infadenopathy with local symptoms. The disease can heal spontaneously but can give more severe manifestations among which they stand out:

Long-Term Complications of Cat Scratch Disease

Chronic Lymphadenopathy:

In some cases, lymph nodes may remain swollen for months or even years after the initial infection. This can cause discomfort and require medical follow-up.

Disseminated Infections:

In severe cases, Bartonella henselae can spread to other organs, such as the liver, spleen, lungs, and central nervous system. This can result in more serious complications, such as hepatitis or pneumonia.

Ocular Complications:

CSD can cause eye problems, such as retinitis, which can lead to vision loss if not treated properly. This is more common in immunocompromised people. Parinaud's oculoglandular syndrome, neuroretinitis, uveitis.


Neurological Symptoms:

Rarely, the disease can affect the nervous system, causing symptoms such as confusion, seizures, or encephalitis.

Persistent Fatigue:

Some people may experience prolonged fatigue and malaise that persists long after other symptoms have disappeared.

Arthritis:

Although rare, some patients may develop arthritis or joint pain as a result of the infection.

In summary:


 GENERAL: Discomfort. Fever, anorexia, weight loss.
 SKIN: Subcutaneous nodules and abscesses.
 HIGAGO: Granulomatous hepatitis, Hepatomegaly, hepatic abscess.
 BAZO: Splenomegaly, splenic abscesses.
 BRAIN: Encephalitis, meningitis, seizures
 SPINAL CORD: transverse myelitis.
 HEART: Endocarditis.
 BLOOD: Bacteremia
 EYE: Parinaud's oculoglandular syndrome, neuroretinitis, uveitis.

The Bartonella Hanselae also produces another disease called bacillary angiomatosis, which is seen more in immunocompromised patients.

Treatment:

Treatment options for cat scratch disease are:

1.) Local Heat Application:
This measure is recommended in the affected area to relieve pain and inflammation.

2.) Analgesics: to relieve pain and inflammation.

3.) Antibiotics: The literature states that they are not always necessary, but the better way is to administer antibiotics to prevent the spread of infection, and the eligible ones are; azithromycin or doxycycline to help reduce the inflammation of the lymph nodes and shorten the duration of symptoms.

However, its use is controversial and is not considered essential in all cases.

In a study of 268 patients with this pathology, the effectiveness of 4 (four) antibiotics was demonstrated: they were rifampicin 87%, ciprofloxacin 84%, trimethoprim-sulfamethoxazole 58%. Intramuscular gentamicin sulfate was 73% effective.

In cases where lymph node suppuration is present, intranodal injection of gentamicin has been used successfully.

In cases of ocular involvement, topical drops of 0.5% ketorolac twice a day and 0.05% difluprednate four times a day have been used for more than 6 weeks.

4.) In immunosuppressed patients(HIV/AIDS) or autoimmune diseases: treatment should be more aggressive:


Apart from the classic analgesics and local measures (heat), antibiotic therapy should be mandatory: azithromycin, doxycycline, rifampicin or gentamicin, ciprofloxacin, trimethoprim-sulfamethoxazole.

The incidence of CAT SCRATCH DISEASE disease in the United States between 2005 and 2013 in children between 5 and 9 years of age was 9.4 cases per 100,000 population. The most affected age group was 50 to 64 years. About 12.000 new cases are estimated each year, of which 500 are hospitalized.

The best preventive measure, control the flea of ​​the cat and of course avoid the biting or scratches of the cute kittens.


Through these 49 references you will know the disease, its complications and the therapeutic alternatives.
In the attachment, the cat, the child, the initial papule and the posterior lymphadenopathy.

Greetings to all.

Dr. José Lapenta

La enfermedad por arañazo de gato



EDITORIAL ESPAÑOL
==================

Hola amigos de la red. De nuevo el DERMAGIC EXPRESS con un tema bien interesante sobre las mascotas, en este caso los lindos gatitos. El tema de hoy LA ENFERMEDAD POR ARAÑAZO DE GATO. 

Enfermedad Zoonótica transmitida por la mordedura o arañazos de nuestras mascotas, lindos gatitos. El agente causal de esta enfermedad es la bacteria Bartonella Henselae, según los científicos mas de la mitad de los gatos son portadoras de la misma. La bacteria es transmitida de gato a gato por la pulga del gato Ctenocephalides felis.

La enfermedad comienza como una pápula en el sitio de la inoculación. la cual se transforma en pústula y posteriormente una linfadenopatia regional con síntomas locales. La enfermedad puede sanar espontáneamente pero puede dar manifestaciones mas severas entre las que destacan:

Complicaciones a Largo Plazo de la Enfermedad por Arañazo de Gato

Linfadenopatía Crónica:

En algunos casos, los ganglios linfáticos pueden permanecer inflamados durante meses o incluso años después de la infección inicial. Esto puede causar molestias y requerir seguimiento médico.

Infecciones Diseminadas:

En casos severos, la Bartonella henselae puede diseminarse a otros órganos, como el hígado, el bazo, los pulmones y el sistema nervioso central. Esto puede resultar en complicaciones más graves, como hepatitis o neumonía.

Complicaciones Oculares:

La CSD puede causar problemas oculares, como la retinitis, que puede llevar a la pérdida de visión si no se trata adecuadamente. Esto es más común en personas inmunocomprometidas.
Síndrome óculo glandular de Parinaud, neuro retinitis, uveítis.

Síntomas Neurológicos:

En raras ocasiones, la enfermedad puede afectar el sistema nervioso, causando síntomas como confusión, convulsiones o encefalitis.

Fatiga Persistente:

Algunas personas pueden experimentar fatiga prolongada y malestar general que persiste mucho después de que otros síntomas han desaparecido.

Artritis:

Aunque es poco común, algunos pacientes pueden desarrollar artritis o dolor articular como resultado de la infección.
 

Resumiendo:

GENERALES: Malestar. fiebre, anorexia, perdida de peso.
PIEL: Nódulos subcutaneos y abscesos.
HIGAGO: Hepatitis granulomatosa, Hepatomegalia, absceso hepático.
BAZO: Esplenomegalia, abscesos esplénicos.
CEREBRO: Encefalitis, meningitis, convulsiones
MÉDULA ESPINAL: mielitis transversa.
CORAZÓN: Endocarditis.
SANGRE: Bacteriemia
OJO: Síndrome óculo glandular de Parinaud, neuro retinitis, uveítis.

La Bartonella Henselae también produce otra enfermedad denominada angiomatosis bacilar, la cual se observa mas en pacientes inmunocomprometidos.

Tratamiento:

las opciones de tratamiento para la enfermedad por arañazo de gato son:    

1.) Aplicación de Calor Local:
Esta medida se recomienda en la zona afectada para aliviar el dolor y la inflamación.

2.) Analgésicos: para aliviar el dolor e inflamación.

3.) Antibióticos: La literatura refiere que no siempre son necesarios, pero lo ideal es administrar antibióticos para evitar la diseminasion de la infección, y los elegibles son; azitromicina o doxiciclina para ayudar a reducir la inflamación de los ganglios linfáticos y acortar la duración de los síntomas.
Sin embargo, su uso es controvertido y no se considera esencial en todos los casos.

En un estudio de 268 pacientes con esta patología se demostró la efectividad de 4 (cuatro) antibióticos: ellos fueron rifampicina 87%, ciprofloxacino 84%, trimetoprim-sulfametoxazol 58%. El sulfato de gentamicina intramuscular tuvo una eficacia del 73%.

En los casos donde se presenta supuración de los ganglios linfáticos se ha utilizado con éxito la inyección intra-nodal de gentamicina.

En casos de afección ocular se ha utilizado gotas tópicas de ketorolaco al 0,5 % dos veces al día y difluprednato al 0,05 % cuatro veces al día durante más de 6 semanas.

4.) En pacientes inmunodeprimidos (VIH/SIDA) o enfermedades autoinmunes el tratamiento debe ser mas agresivo:

Aparte de los clásicos analgésicos y medidas locales (calor), la antibiótico terapia debe ser obligatoria: azitromicina, doxiciclina, rifampicina o gentamicina, ciprofloxacino, trimetoprim-sulfametoxazol.

La incidencia de la enfermedad por ARAÑAZO DE GATO EN los Estados Unidos entre 2.005 y 2.013 en niños entre 5 y 9 años de edad fue de 9,4 casos por 100.000 habitantes. El grupo etario mas afectados fue de 50 a 64 años. Se estiman unos 12.000 casos nuevos al año, de los cuales 500 son hospitalizados.
 
la mejor medida preventiva, controlar la pulga del gato y por supuesto evitar la mordedura o arañazos de los lindos gatitos.

A través de estas 49 referencias conocerás la enfermedad, sus complicaciones y las alternativas terapéuticas.

En el adjunto, el gato, el niño, la pápula inicial y la posterior linfadenopatia.

Saludos a todos,,,

 Dr. José Lapenta R.,,,
 

================================================================
REFERENCIAS BIBLIOGRÁFICAS / BIBLIOGRAPHICAL REFERENCES
================================================================

1.) The Cat-Scratch Disease.
2.) Cat scratch disease: detection of Bartonella henselae DNA in archival biopsies from patients with clinically, serologically, and histologically defined disease. 
3.) [A case of cat scratch disease identified by an elevated Bartonella henselae antibody level using enzyme immunoassay] 
4.) Will the real agent of cat-scratch disease please stand up? 
5.) [Cat scratch disease caused by Bartonella henselae] 
6.) Hypercalcemia due to endogenous overproduction of active vitamin D in identical twins with cat-scratch disease. 
7.) Cat-scratch disease caused by Bartonella henselae: the first case report in Taiwan. 
8.) [Cat-scratch disease and other infections caused by Bartonella species] 
9.) Bartonella spp. as emerging human pathogens.
10.) [Bartonella henselae infection in immunocompetent patients: cat scratch disease] 
11.) Cat-scratch disease and related clinical syndromes. 
12.) Cat-scratch disease and bacillary angiomatosis. 
13.) Detection of antibodies to Bartonella henselae in clinically diagnosed cat scratch disease. 
14.) The expanding spectrum of Bartonella infections: II. Cat-scratch disease.
15.) Evaluation of serological response to Bartonella henselae, Bartonella quintana and 
Afipia felis antigens in 64 patients with suspected cat-scratch disease.
16.) [Cat scratch disease and associated infections] 
17.) Cat-scratch disease simulating Histiocytosis X. 
18.) [Atypical cat-scratch disease: a case report of splenic granulomatosis] 
19.) [2 patients with atypical manifestations of cat-scratch disease]
20.) [Visceral localizations of cat-scratch disease in an immunocompetent patient] 
21.) Serous retinal detachment of the macula associated with cat scratch disease. 
22.) Cat scratch disease in Greece. 
23.) Cat-scratch disease--an overlooked disease in Denmark?]
24.) Prolonged Bartonella bacteremia in cats associated with cat-scratch disease patients. 
25.) Application of polymerase chain reaction assay in the diagnosis of orbital granuloma complicating atypical oculoglandular cat scratch disease. 
26.) Systemic cat scratch disease: hepatic and splenic involvement about 3 pediatric cases. 
27.) Bartonella clarridgeiae, a newly recognized zoonotic pathogen causing inoculation papules, fever, and lymphadenopathy (cat scratch disease). 
28.) Coinfection with Bartonella clarridgeiae and Bartonella henselae and with different Bartonella henselae strains in domestic cats.
29.) [Cat-scratch disease: historical, clinical, phylogenetic and taxonomic aspects]
30.) Molecular diagnosis of cat scratch disease: a two-step approach.
31.) Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature.
32.) Successful treatment of cat-scratch disease with ciprofloxacin [see comments].
33.) Diverse Clinical Signs of Ocular Involvement in Cat Scratch Disease.
34.) Cat Scratch Disease: Expanded Spectrum.
35.) Dynamics of Co-Infection with Bartonella henselae Genotypes I and II in Naturally Infected Cats: Implications for Feline Vaccine Development.
36.)Bacillary angiomatosis with bone invasion.
37.) Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis.
38.) Corticosteroid Treatment for Prolonged Fever in Hepatosplenic Cat-Scratch Disease.
39.) Final Diagnosis in Patients Referred with a Diagnosis of Neuroretinitis.
40.) Disseminated cat-scratch disease: case report and review of the literature.
41.) Multiple Renal and Splenic Lesions in Cat Scratch Disease.
42.) Cat-Scratch Disease in the United States, 2005-2013. 43.) Cat fleas (Ctenocephalides felis) from cats and dogs in New Zealand: Molecular characterisation, presence of Rickettsia felis and Bartonella clarridgeiae and comparison with Australia.
43.) Cat fleas (Ctenocephalides felis) from cats and dogs in New Zealand: Molecular characterisation, presence of Rickettsia felis and Bartonella clarridgeiae and comparison with Australia.
 

 ================================================================

44.) Effectiveness of Antibiotic Therapy in Pediatric Patients With Cat Scratch Disease.
45.) Cat-Scratch Disease.
46.) Antibiotic Therapy for Cat-Scratch Disease: Clinical Study of Therapeutic Outcome in 268 Patients and a Review of the Literature.
47.) Hepatosplenic Cat-Scratch Disease in Children: Selected Clinical Features and Treatment.
48.) Intra-Nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis.
49) Case Report: Treatment of Severe Neuroretinitis and Other Sequelae Associated With Cat Scratch Disease.

===============================================================

================================================================
1.) The Cat-Scratch Disease
=========================================================================

Source: Harrison's 14

DEFINITION AND ETIOLOGY

Typical CSD is manifested by painful regional lymphadenopathy persisting for several weeks or months after a cat scratch. Occasionally, infection may disseminate and produce more generalized lymphadenopathy and systemic manifestations, which may be confused with the manifestations of lymphoma. B. henselae is the causative agent of CSD. There is no evidence that B. quintana or Afipia felis (originally proposed as the agent of CSD) can cause this disease, nor are those two species carried by cats.

EPIDEMIOLOGY

Approximately 60 percent of cases of CSD in the United States occur in children. Exposure to bacteremic young cats that either are flea-infested or have been in contact with another cat carrying fleas poses a significant risk of infection. Most infections are caused by a scratch and only rare cases by a bite or by licking. Most cases occur in the warmer months, when fleas are active. Regions of the United States where fleas are endemic have higher rates of infection. The flea may serve to transmit infection between cats; it is not known whether humans can be infected through the bite of an infected flea.

CLINICAL MANIFESTATIONS

A localized papule (Fig. 165-CD3), progressing to a pustule that often crusts over, develops 3 to 5 days after a cat scratch. Tender regional lymphadenopathy (Fig. 165-CD4) develops within 1 to 2 weeks after inoculation; by this time, the papule may have healed spontaneously. Scratches are most often sustained on the hands or face, producing epitrochlear, axillary, pectoral, and cervical lymph node involvement. The involved nodes occasionally become suppurative; bacterial superinfection with staphylococci or other cutaneous pathogens may develop. Although most patients do not have fever, systemic symptoms are frequent and include malaise, anorexia, and weight loss. Without treatment, lymphadenopathy persists for weeks or even months and may be confused with lymphatic malignancy. Other manifestations in apparently immunocompetent patients include encephalitis, seizures and coma (especially in children), meningitis, transverse myelitis, granulomatous hepatitis and splenitis, osteomyelitis, and disseminated infection. Conjunctival inoculation may cause Parinaud's oculoglandular syndrome, with conjunctivitis and preauricular lymphadenopathy.

PATHOLOGY

The histopathologic hallmark of CSD is granulomatous inflammation with stellate necrosis but no evidence of angiogenesis. Thus, infection by B. henselae can produce two entirely different pathologic reactions, depending on the immune status of the host: CSD or bacillary angiomatosis.

DIAGNOSIS

CSD should be suspected if the patient has a history of exposure to cats and develops lymphadenopathy and a skin lesion. The diagnosis can be confirmed by pathologic examination of the involved nodes. Tiny bacilli in clusters can sometimes be seen in biopsy samples stained with Warthin-Starry silver. The CSD skin test, in which lymph node material obtained from patients with CSD serves as an antigen, is no longer used for diagnosis because of concerns about the transmission of viral agents. A specific serologic test has been developed recently and may produce a positive result in 70 to 90 percent of patients with intact immunity. The identification of B. henselae 16S ribosomal RNA genes in biopsy material by PCR amplification with specific oligonucleotide primers can also be diagnostically useful; however, these methods are not yet commercially available. Cultures of lymph nodes, cerebrospinal fluid, or other tissues are rarely positive.

TREATMENT

Although CSD is generally self-limited, tender regional lymphadenopathy and systemic symptoms may be debilitating. Patients with encephalitis or other serious manifestations should be treated with antibiotics, even though the efficacy of such therapy is unclear. No comparative trials of antibiotic treatment have been performed, and no anecdotal reports of treatment failures have appeared. Several reports suggest that aminoglycoside treatment (e.g., intravenous gentamicin at standard doses calculated to result in therapeutic levels) is effective in patients with encephalitis and other systemic infections. The oral agents that appear to be useful are those that also are most effective for the treatment of bacillary angiomatosis; they include ciprofloxacin, doxycycline, and possibly erythromycin (at the dosages recommended for bacillary angiomatosis). Many patients with established CSD have no apparent response to antibiotics; the necessary duration of therapy is variable.

=========================================================================
2.) Cat scratch disease: detection of Bartonella henselae DNA in archival biopsies from patients with clinically, serologically, and histologically defined disease. 
=========================================================================
Author 
Scott MA; McCurley TL; Vnencak-Jones CL; Hager C; McCoy JA; Anderson B; Collins RD; Edwards KM 
Address 
Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA. 
Source 
Am J Pathol, 149(6):2161-7 1996 Dec 

Abstract 

Serological and epidemiological studies suggest that Bartonella henselae is the etiological agent of cat scratch disease. We designed a study to detect B. henselae in archival biopsies by polymerase chain reaction amplification of the 16S rRNA gene followed by Southern blot hybridization. Forty-two histologically defined cat scratch disease biopsies and eighteen controls were selected for blinded analysis. After testing, charts were reviewed for clinical, immunological, and microbial evidence of infection.

Results were correlated with duration of illness and antimicrobial therapy. B. henselae DNA was identified in 27 of 42 (64%) histologically defined patients and 23 of 34 (68%) patients defined both clinically and histologically. There were no false positives (0 of 18). A small subset (n = 14) had cat scratch disease serological tests performed. B. henselae was identified in 8 of 10 serologically positive patients. Polymerase chain reaction detected 50% of our DNA-positive cases (most of these early in the clinical course).

Southern blotting of amplicons both doubled sensitivity (detecting patients > 4 weeks into illness) and confirmed B. henselae as the causative species. Our study strongly associates B. henselae with cat scratch disease, suggesting that it may be the most likely etiological agent in the majority of patients with cat scratch disease. 

=========================================================================
3.) [A case of cat scratch disease identified by an elevated Bartonella henselae antibody level using enzyme immunoassay] 
=========================================================================
Author 
Kusaba N; Nakamura H; Yoshimoto K; Ogata H; Sata M; Tanikawa K; Kusaba A; Yoshida H 
Address 
Second Department of Medicine, Kurume University School of Medicine. 
Source 
Kansenshogaku Zasshi, 71(10):1075-9 1997 Oct 

Abstract 

A 68-year-old male was admitted to our hospital because of fever and a 2-week history of inguinal adenomegaly. Since he owned a cat, cat scratch disease was suspected. But it was necessary to distinguish cat scratch disease from lymphoma type adult T-cell leukemia because he showed a high level of antibody against HTLV-1. An excisional biopsy of the inguinal node was performed. Histopathologic examination revealed abscess-forming granulomatous lymphadenitis compatible with cat scratch disease.

A Warthin-Starry silver stain showed pleomorphic bacilli in the lymph node. So we confirmed a serological response to Bartonella henselae, the causative agent of cat scratch disease, using enzyme immunoassay (EIA). The IgG antibody level to B. henselae was positive at 42 EIA Unit before treatment. After treatment with intravenous cefepime and oral tosufloxacin, his physical symptoms improved and the antibody level decreased to less than 12 EIA Unit. EIA was very useful for diagnosis of this case. Serology to B. henselae may replace traditional diagnostic criteria for cat scratch disease. 

=========================================================================
4.) Will the real agent of cat-scratch disease please stand up? 
=========================================================================
Author 
Jerris RC; Regnery RL 
Address 
Emory University, Department of Pathology and Laboratory Medicine, Atlanta, Georgia 30322, USA. 
Source 
Annu Rev Microbiol, 50():707-25 1996 

Abstract 

Cat-scratch disease has been recognized since 1889 in association with the oculoglandular syndrome of Parinaud. The epidemiologic association with cats was first made in 1931 and further substantiated throughout the years, refining the interaction predominantly to kittens. Putative infectious agents have included numerous species of bacteria, chlamydiae, and viruses.

The cultivation of Afipia spp. in the late 1980s appeared to answer the mystery of the identity of the agent. However, even more recent analysis, which has combined traditional microbiology, molecular methods, and additional epidemiology, has demonstrated that Bartonella (Rochalimaea) henselae is the definitive agent of cat-scratch disease. Our understanding of the pathogenesis of cat-scratch disease and other diseases caused by Bartonella species is incomplete and the spectrum of diseases continues to emerge. We review historic and modern efforts to understand the etiology of cat-scratch disease and related syndromes. 

=========================================================================
5.) [Cat scratch disease caused by Bartonella henselae] 
=========================================================================
Author 
S¨older B; Allerberger F; Covi B; Maurer K; Scheminzky C; Kreczy A; Sch¨on G; Dierich MP 
Address 
Klinik f¨ur Kinder- und Jugendheilkunde, Universit¨at Innsbruck. 
Source 
Immun Infekt, 23(6):228-31 1995 Dec 

Abstract 

Bartonella henselae is an etiologic agent of cat-scratch disease and, in immunocompromised patients, of bacillary angiomatosis and other severe syndromes. Cat-scratch disease usually presents as lymphadenopathy, which resolves spontaneously within 2-4 months.

The utility of antibiotic therapy remains controversial. In Tyrol four cases of human cat-scratch disease were diagnosed in children in 1994, yielding a prevalence of 0.7/100,000 per year. A 3-year-old boy had lymphadenitis coli since one year despite antituberculosis therapy which was initiated because of the histopathological picture and a positive tuberculin reaction (despite negative mycobacteria-cultures and -PCR). Two girls, age 9 and 13 years, had lymphadenitis at upper or lower extremities after cat-scratches from kittens. A 13-year-old boy presented with febrile illness and right hip pain, computer tomography revealed an osteolytic lesion; symptoms subsided within 3 weeks.

Diagnosis of cat-scratch disease is based on cat contact, negative studies for other similar diseases, characteristic histopathologic features (if available), and results of an indirect immunofluorescence test (antigen: Houston-1 isolate, ATCC 49882). We believe that the availability of this serological test will increase the number of diagnosed cases of human Bartonella henselae infections. 

=========================================================================
6.) Hypercalcemia due to endogenous overproduction of active vitamin D in identical twins with cat-scratch disease. 
=========================================================================
Author 
Bosch X 
Address 
Internal Medicine Unit, Hospital Casa Maternitat, Corporaci´o Sanit`aria Clinic, Barcelona, Spain. 
Source 
JAMA, 279(7):532-4 1998 Feb 18 

Abstract 

CONTEXT: The extrarenal synthesis of active vitamin D sterols has a central causative role in the hypercalcemia associated with various granulomatous diseases.

OBJECTIVE: To study the calcium metabolism in patients with cat-scratch disease who have hypercalcemia. DESIGN: Case report.

SETTING: University hospital in Barcelona, Spain.

PATIENTS: Two identical twins who developed asymptomatic hypercalcemia during the acute phase of cat-scratch disease.

MAIN OUTCOME MEASURES: Serial measures of calcium homeostasis and metabolism over a 2-month period.

RESULTS: On admission and 6 and 7 days later, both patients were found to have increased levels of serum and urinary calcium, serum phosphate, and serum 1,25-dihydroxyvitamin D [1,25(OH)2D], whereas they had normal values of serum 25-hydroxyvitamin D and urinary cyclic adenosine monophosphate and decreased serum concentrations of intact parathyroid hormone. Sixteen and 20 days after admission, these abnormalities had resolved without treatment. A direct correlation was observed between the serum 1,25(OH)2D levels and both the serum and 24-hour urinary calcium concentrations. Also, the concentrations of calcium and 1,25(OH)2D paralleled the clinical activity of the infectious disease over the period these parameters were measured.

CONCLUSIONS: Our cases provide evidence that cat-scratch disease can produce hypercalcemia through the unregulated production of the metabolite 1,25(OH)2D. Cat-scratch disease should be added to the list of granuloma-forming diseases that are responsible for 1,25(OH)2D-mediated hypercalcemia. 

=========================================================================
7.) Cat-scratch disease caused by Bartonella henselae: the first case report in Taiwan. 
=========================================================================
Author 
Lee SC; Fung CP; Lee N; Shieh WB 
Address 
Department of Pathology, Chang Gung Memorial Hospital, Keelung, Taiwan. 
Source 
J Formos Med Assoc, 97(8):569-72 1998 Aug 

Abstract 

We report a typical case of cat-scratch disease caused by Bartonella henselae, in Taiwan. A 20-year-old man developed right axillary lymphadenopathy 2 weeks after being scratched on his right hand by a kitten. The axillary lymphadenopathy resolved gradually and spontaneously after 10 weeks without specific treatment. Serologic tests were not done during the acute stage of the event.

However, an immunofluorescent antibody test performed during the convalescent stage was positive for B. henselae antibodies, and the concentration dropped by fourfold 2 months later. Histopathologic examination of a biopsy specimen from the right axillary lymph node revealed findings characteristic of cat-scratch disease including multiple foci of microabscesses surrounded by histiocytes and infiltration by plasma cells and lymphocytes. This is the first reported case of cat-scratch disease in Taiwan, with a history of contact with a cat, a positive serologic test for B. henselae infection and characteristic histopathologic findings of cat-scratch disease which met the criteria for diagnosis. 

=========================================================================
8.) [Cat-scratch disease and other infections caused by Bartonella species] 
=========================================================================
Author 
Schellekens JF 
Address 
Rijksinstituut voor Volksgezondheid en Milieu, Laboratorium voor Bacteriologie en Antimicrobi¨ele Middelen, Bilthoven. 
Source 
Ned Tijdschr Geneeskd, 140(3):144-7 1996 Jan 20 

Abstract 

Bartonella henselae, the causative agent of cat-scratch disease, was identified recently by DNA amplification techniques. Several other Bartonellae (most of which were called Rochalimaea before) cause disease in humans: B. bacilliformis (Carrion's disease), B. elizabethae (endocarditis) and B. quintana (bacillary angiomatosis and peliosis, chronic bacteraemia and endocarditis, trench fever). B. henselae is transmitted to humans by scratch or bite of a bacteraemic, but asymptomatic, cat, which event may be followed by regional lymphadenitis (classical cat-scratch disease), bacillary angiomatosis or peliosis of liver and spleen (in immune compromised, e.g. HIV-infected individuals) or chronic bacteraemia and endocarditis (in elderly individuals).

The incidence in the Netherlands of cat-scratch disease is > 2/100,000/year. If a Bartonella infection is suspected, specific immuno-assays and polymerase chain reaction assay may be applied for diagnosis. Culture of the organism is difficult. Macrolides and tetracyclines have been shown to be effective in treatment of disseminated infections. The natural (self-limiting) course of regional lymphadenitis however is not affected by antibiotic treatment. 

=========================================================================
9.) Bartonella spp. as emerging human pathogens.
=========================================================================
Anderson BE; Neuman MA
Department of Medical Microbiology and Immunology, College of Medicine, University 
of South Florida, Tampa 33612, USA. banderso@com.1.med.usf.edu Clin Microbiol Rev (UNITED STATES) Apr 1997 10 (2) p203-19 ISSN: 0893-8512 Contract/Grant No.: R29-AI38178--AI--NIAID
Language: ENGLISH
Document Type: JOURNAL ARTICLE; REVIEW; REVIEW, ACADEMIC 
Journal Announcement: 9709

Subfile: INDEX MEDICUS

Members of the genus Bartonella (formerly Rochalimaea) were virtually unknown to  modern-day clinicians and microbiologists until they were associated with  opportunistic infections in AIDS patients about 6 years ago. Since that time,  Bartonella species have been associated with cat scratch disease, bacillary  angiomatosis, and a variety of other disease syndromes.

Clinical presentation of  infection with Bartonella ranges from a relatively mild lymphadenopathy with few  other symptoms, seen in cat scratch disease, to life-threatening systemic disease in  the immunocompromised patient. In some individuals, infection manifests as lesions  that exhibit proliferation of endothelial cells and neovascularization, a pathogenic  process unique to this genus of bacteria. As the spectrum of disease attributed to  Bartonella is further defined, the need for reliable laboratory methods to diagnose  infections caused by these unique organisms also increases. A brief summary of the  clinical presentations associated with Bartonella infections is presented, and the  current status of laboratory diagnosis and identification of these organisms is  reviewed. (205 References)

=========================================================================
10.) [Bartonella henselae infection in immunocompetent patients: cat scratch disease] 
=========================================================================
Author 
Abarca K; Vial PA; Rivera M; Garc´ia C; Odd´o D; Prado P; Ferr´es M 
Address 
Departamentos de pediatr´ia, de Radiolog´ia y Anatom´ia Patol´ogica, Facultad de Medicina, Pontificia Universidad Cat´olica de Chile, Santiago, Chile. 
Source 
Rev Med Chil, 124(11):1341-9 1996 Nov 

Abstract 

BACKGROUND: Cat scratch disease, whose etiologic agent is Bartonella henselae, is a benign disease in immunocompetent subjects, characterized by lymphadenopathy of prolonged course and occasional involvement of other organs such as liver, spleen, central nervous system, eye and lung. In immunocompromised patients, the infection is bacteremic and disseminated. AIM: To report Chilean cases of cat scratch disease.

PATIENTS AND METHODS: Ten children (seven male, aged between 6 and 13 years old) with histologically or serologically confirmed cat scratch disease are reported.

RESULTS: Lymphadenopathy location was pre auricular in four cases, axillary in two, inguinal in two and epitrochlear in two. Three children had fever over 39 degrees C and two had a parinaud syndrome. Nine children had a history of cat scratch and one of a cat byte. Six had an erythrocyte sedimentation rate over 40. Lymph node ultrasound examination was a useful diagnostic tool. Two patients had splenic granulomas. Lymph node biopsies were obtained in four cases, showing a suppurative granulomatous lymphadenitis in all and a positive Warthin-Starry stain in two. Serology, done in patients without histological confirmation was positive with titles ranging from 1:64 to 1:8192. All patients had a satisfactory outcome with regression of lymphadenopathy.

CONCLUSIONS: Infections by Bartonella hemselae occur in the Chilean population and must be considered in the differential diagnosis of regional lymph node enlargement. 

=========================================================================
11.) Cat-scratch disease and related clinical syndromes. 
=========================================================================
Author 
Smith DL 
Address 
West Jersey Family Practice Residency, Voorhees, New Jersey, USA. 
Source 
Am Fam Physician, 55(5):1783-9, 1793-4 1997 Apr 

Abstract 

Bartonella (Rochalimaea) henselae is a common cause of cat-scratch disease. This newly identified bacterium is also the cause of several other clinical syndromes, including bacillary angiomatosis, bacillary peliosis hepatitis and splenitis, and acute and relapsing bacteremia. A high percentage of young cats carry B. henselae. Fortunately, serious complications of B. henselae infections are rare in immunocompetent patients. Cat-scratch disease is usually a self-limited illness that does not necessarily require antibiotic therapy. Severe or persistent cases respond well to several antibiotics, including erythromycin and doxycycline.

Cat-scratch disease should be included in the differential diagnosis of serious neurologic disease, particularly when regional lymphadenopathy develops suddenly in a previously healthy patient who owns a cat. Treatment of uncomplicated central nervous system disease is generally supportive. Antibiotic therapy is reserved for patients with atypical or severe involvement, including encephalopathy and retinitis. Other internal and cutaneous manifestations of B. henselae infection have recently been described. These potentially life-threatening infections respond well to antibiotic therapy, even in immunocompromised patients. 

=========================================================================
12.) Cat-scratch disease and bacillary angiomatosis. 
=========================================================================
Author 
Chomel BB 
Address 
Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis 95616, USA. 
Source 
Rev Sci Tech, 15(3):1061-73 1996 Sep 

Abstract 

Cat-scratch disease (CSD) was first described by Debr´e in 1950, yet the causative bacterial agent of CSD remained obscure until 1992, when Bartonella (formerly Rochalimaea) henselae was implicated in CSD by serological and microbiological studies. B. henselae had initially been linked to bacillary angiomatosis (BA), a vascular proliferative disease most commonly associated with long-standing human immunodeficiency virus (HIV) infection or other significant immunosuppression. B. henselae has also been associated with bacillary peliosis, relapsing bacteraemia and endocarditis in humans.

Cats are healthy carriers of B. henselae, and can be bacteraemic for months or years. It has recently been demonstrated that B. henselae can be transmitted from cat to cat by the cat flea, but not by direct contact between animals. The author discusses the present state of knowledge on the aetiology, clinical features and epidemiological characteristics of cat-scratch disease and bacillary angiomatosis. 

=========================================================================
13.) Detection of antibodies to Bartonella henselae in clinically diagnosed cat scratch disease. 
=========================================================================
Author 
Flexman JP; Chen SC; Dickeson DJ; Pearman JW; Gilbert GL 
Address 
Department of Clinical Microbiology and Infectious Diseases, Royal Perth Hospital, WA. jameflex@dunamis.rph.uwa.edu.au 
Source 
Med J Aust, 166(10):532-5 1997 May 19 

Abstract 

OBJECTIVE: To determine the usefulness of an indirect immunoflourescence antibody test for antibodies to Bartonella henselae in diagnosing cat scratch disease (CSD).

DESIGN AND SETTING: Retrospective case survey of 354 patients whose sera were tested for antibodies to B. henselae at Royal Perth Hospital, Perth, and the Institute of Clinical Pathology and Medical Research, Sydney. In 1994; and measurement of the background prevalence of antibodies to B. henselae.

MAIN OUTCOME MEASURES: Prevalence of antibodies to B. henselae, odds of a positive titre (> or = 64) in patients with and without specific risk factors for CSD and clinical features of the disease; prevalence of antibodies to B. henselae in randomly selected blood donors.

RESULTS: Demographic, clinical and cat contact data were available for 303 patients. Sixty-four (21.1%) had a positive titre, as did 53 of 98 (54%) patients with a history of cat contact and lymphadenopathy. This proportion increased to 62% (38 of 61 patients) in patients with a history of cat scratch or bite and to 90.3% (28 of 31) in those with cat contact, lymphadenopathy and histological evidence of granulomatous lymphadenitis. Patients who developed lymphadenopathy after cat contact were significantly more likely to have a positive titre than those without this history (odds ratio [OR], 20.8; 95% confidence interval [95% Cl], 9.6-46; P < 0.0001). Inclusion of a history of a cat scratch or bite significantly raised the odds of being seropositive (OR, 13.7; 95% Cl, 6.8-28.1; P < 0.0001), and the presence of granulomas on lymph node biopsy further increased the odds (OR, 124.4; 95% Cl, 19.4-1073; P < 0.0001). The prevalence of antibodies to B. henselae in random blood donors in New South Wales was about 5% (five of 102 sera samples).

CONCLUSIONS: The immunofluorescence antibody test for B. henselae can be expected to be positive in just over half the patients with clinically suspected CSD, and it has a positive predictive value of 83%. In a significant number of cases the diagnosis cannot be made on the basis of the results of immunofluorescence antibody testing alone and further investigations, including lymph node biopsy, may be required. 

=========================================================================
14.) The expanding spectrum of Bartonella infections: II. Cat-scratch disease.
=========================================================================
Bass JW; Vincent JM; Person DA
Department of Pediatrics, Tripler Army Medical Center, Honolulu, HI 96859-5000, 
USA. jamess.bass@ches.tamc.amedd.army.mil
Pediatr Infect Dis J (UNITED STATES) Feb 1997 16 (2) p163-79 ISSN: 0891-3668
Language: ENGLISH
Document Type: HISTORICAL ARTICLE; JOURNAL ARTICLE; REVIEW; REVIEW, ACADEMIC 
Journal Announcement: 9706

Subfile: INDEX MEDICUS

Recent advancements and developments in molecular biotechnology have allowed more  precise reclassification of many microorganisms. With the use of these new taxonomy  tools, several organisms previously thought to belong to other genera have been  recently described as bartonellae. Of the 11 organisms now described as Bartonella  spp., only four have been shown to be pathogenic for humans.

Table 1 lists the four  Bartonella human pathogens along with the their known epidemiology and the scope and  range of disease associated with each. All are now considered to be bacteria and can  be grown on blood-enriched agar although primary isolation in some may best be  achieved in cell tissue culture. B. bacilliformis infection is limited to certain  geographic regions in South America where the only human reservoir and the sandfly  vector(s) that spreads the disease reside together. Specific antibiotic treatment is  dramatically effective in treating the highly fatal, acute intraerythrocytic  hemolytic form of the disease, but their effectiveness in treating the vascular  proliferative forms (verruga peruana) or the chronic asymptomatic, bacteremic,  carrier state of the disease has not been effective.

This disease should remain  confined to its present endemic geographic areas in South American unless  asymptomatic bacteremic persons from these areas migrate to areas where sandflies and  humans exist that are capable of establishing this infection in new endemic areas.  B. quintana and B. henselae cause a wide range of clinical diseases in humans, the  type and extent of which varies significantly with the immune status of the host. In  immunocompetent hosts the pathologic response is granulomatous, suppurative,  extracellular and intracellular, generally self-limited and usually unresponsive to  antibiotic treatment, even to those drugs to which the organism is shown to be  sensitive in vitro. In contrast, in immunocompromised hosts the pathologic response  is vasculoproliferative, organisms may be seen intracellularly but they are often  seen in abundance in extracellular clumps and infection is usually progressive and  fatal unless treated.

In these patients clinical response to treatment with drugs  that are effective in vitro against these organisms has usually been dramatic. Of  these agents those that penetrate cells and are found in high concentrations  intracellularly, such as erythromycin, clarithromycin, azithromycin, rifampin,  doxycycline and gentamicin, appear to be most effective.

These agents not only  appear to provide the most dramatic treatment response in patients with BA, BP and  PRFB and other manifestations of B. henselae (and B. quintana as well) in  immunocompromised persons, they appear to be the most promising agents for treatment  of persons with both typical and atypical CSD. Further studies will be necessary to  more clearly elucidated the mechanisms responsible for the diverse clinical  presentations of infection with these organisms in human hosts relative to their  immune status. In addition clarification of the epidemiology of B. elizabethae  infections in humans may be helpful in understanding the nature of infection with  Bartonella organisms. (215 References)

=========================================================================
15.) Evaluation of serological response to Bartonella henselae, Bartonella quintana and  Afipia felis antigens in 64 patients with suspected cat-scratch disease.
=========================================================================
Dupon M; Savin De Larclause AM; Brouqui P; Drancourt M; Raoult D; De Mascarel A;  Lacut JY
Service de Maladies Infectieuses et Medecine Interne, Hopital Pellegrin, France.
Scand J Infect Dis (SWEDEN) 1996 28 (4) p361-6 ISSN: 0036-5548
Language: ENGLISH
Document Type: JOURNAL ARTICLE 
Journal Announcement: 9704

Subfile: INDEX MEDICUS

The serological response to Bartonella henselae, B. quintana, and Afipia felis was  assessed by an indirect fluorescence antibody test (IFAT) in 64 patients with  suspected cat-scratch disease (CSD) recruited from the Bordeaux area in France. 

Blood samples were collected from 57 patients with chronic lymphadenopathy who  underwent lymph-node biopsy with suggestive histopathologic features of CSD, and from  an additional 7 patients with suspected CSD who underwent surgical incision and  drainage because of lymph-node tenderness. Of the patients, 31 were male and 33  female, with a median age of 27 years (range 2-89). 69.8% reported cat and/or dog  contact. Of the 26/64 (40.6%) patients, serum samples were positive at a titer of  1:100 or more for immunoglobulin G (IgG) antibodies (17 only to B. henselae, 1 only  to B. quintana, 3 only to Afipia felis, and 5 to both B. henselae and B. quintana).  IgM or IgA antibodies were also detected in 10 patients with IgG antibodies to B.  henselae. 11 (17.2%) of the 64 patient serum samples were positive at a low titer of  1:50.

These data suggested that serological response assessed by standard IFAT is  not enough to confirm a CSD diagnosis.

=========================================================================
16.) [Cat scratch disease and associated infections] 
=========================================================================
Author 
Chomel BB; Boulouis HJ; Gurfield AN; Heller R; Pi´emont Y; Pilet C 
Address 
Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, USA. 
Source 
Bull Acad Natl Med, 181(3):441-50; discussion 451-4 1997 Mar 18 

Abstract 

Cat scratch disease (CSD) was first described in France by Debr´e et al. in 1950, yet the causative bacterial agent of CSD remained obscure until 1992, when Bartonella (formerly Rochalimaea) henselae was implicated in CSD by serological and microbiologic studies. B. henselae had been linked initially to bacillary angiomatosis (BA), but also bacillary peliosis, relapsing bacteremia and endocarditis.

Cats are healthy carriers of B. henselae and B. clarridgeiae, and can be bacteremic for months to years. Cat to cat transmission of the organism involves the cat flea in absence of direct contact transmission. Present knowledge on the etiology, clinical features and epidemiological characteristics of cat scratch disease/bacillary angiomatosis are presented. 

=========================================================================
17.) Cat-scratch disease simulating Histiocytosis X. 
=========================================================================
Author 
Berg LC; Norelle A; Morgan WA; Washa DM 
Address 
Department of Pathology, Gunderson Clinic, Ltd, LaCrosse, WI 45601, USA. 
Source 
Hum Pathol, 29(6):649-51 1998 Jun 

Abstract 

Cat-scratch disease is a self-limited condition commonly causing a benign chronic lymphadenopathy in children. Osteolytic lesions are a rare complication, but have been previously reported. We report a case of a solitary osteolytic lesion of the skull whose clinical, radiographic and pathological features were initially interpreted as being consistent with Histiocytosis X. Subsequently, positive serological titers for Bartonella, a history of a cat-scratch antecedent to the onset of clinical symptoms and review of the original histopathology confirmed the diagnosis of cat-scratch disease. We reviewed the English language literature on osteolytic lesions associated with cat-scratch disease and compare the current case with those previously reported. 

=========================================================================
18.) [Atypical cat-scratch disease: a case report of splenic granulomatosis] 
=========================================================================
Author 
Dodi I; Iughetti L; Nasi S; Rossi C; Caselli G; Malvicini R 
Address 
Divisione di Pediatria, Ospedale Civile di Fidenza PR, Italia. 
Source 
Pediatr Med Chir, 19(2):143-4 1997 Mar-Apr 

Abstract 

Generally cat-scratch disease is a benign inflammatory adenopathy. The Authors describe an atypical form of this disease, characterized by persistent fever and splenic granulomatosis requiring a diagnostic and therapeutic prolonged effort. They point out the important role of new immuno-fluorescent techniques to exactly identify the bacterium--Bartonella henselae--causing cat-scratch disease and suggest to include cat-scratch disease among the causes of unknown origin fever. 

=========================================================================
19.) [2 patients with atypical manifestations of cat-scratch disease] Twee patienten met atypische manifestaties van kattenkrabziekte.
=========================================================================
Kusumanto YH; Veenhoven RH; Bokma JA; Schellekens JF Spaarne Ziekenhuis, afd. Kindergeneeskunde, Haarlem. Ned Tijdschr Geneeskd (NETHERLANDS) Feb 22 1997 141 (8) p385-7 ISSN: 0028-2162
Language: DUTCH Summary Language: ENGLISH
Document Type: 
JOURNAL ARTICLE English Abstract
Journal Announcement: 9707
Subfile: INDEX MEDICUS

In 2 boys aged 8 years and 10 months, respectively, uncommon manifestations of cat  scratch disease were seen. The first patient had acute encephalopathy: coma and  generalized tonic-clinic convulsions. The second patient was presented with fever  and peripheral lymphadenopathy in combination with hypodense lesions in the liver on  ultrasound. Diagnosis was established on the clinical picture and the positive  results of serological testing of antibody titres for Bartonella henselae. Both  patients recovered completely within 2 months.

=========================================================================
20.) [Visceral localizations of cat-scratch disease in an immunocompetent patient] 
=========================================================================
Author 
Bouchard O; Bosseray A; Leclercq P; Micoud M 
Address 
H^opital Michallon, CHU de Grenoble. 
Source 
Presse Med, 25(5):199-201 1996 Feb 10 

Abstract 

Locoregional expression of cat scratch disease is well known, but despite advances in microbiology over the last 10 years leading to the description of two new bacteria (Afipia felis, Bartonella henselae) the infective agent responsible for cat scratch syndrome remains unknown. Until the 80s, only one systemic disease was attributed to infection with a germ in the Bartonella genus: trench fever.

With the onset of the AIDS epidemic, new clinical syndromes caused by Bartonella bacteria have been described: bacillary angiomatosis, hepatic peliosis, cases of recurrent septicemia, cases of endocarditis, etc. More recently, atypical forms of cat scratch disease including systemic diseases have been reported in immunocompetent subjects. Although quite rare (1% of the cases), such types of expression can raise questions as to diagnosis both in terms of clinical signs and in terms of bacteriological findings.

Clinical and experimental data do not provide a clear direction for treatment but would suggest that prolonged use of aminoglycosides is useful. 

=========================================================================
21.) Serous retinal detachment of the macula associated with cat scratch disease. 
=========================================================================
Author 
Zacchei AC; Newman NJ; Sternberg P 
Address 
Department of Ophthalmology, Emory University School of Medicine, New York, New York, USA. 
Source 
Am J Ophthalmol, 120(6):796-7 1995 Dec 

Abstract 

PURPOSE: We studied an unusual ocular manifestation of cat scratch disease.

METHODS: We examined a patient who had a serous retinal detachment of the macula with vision loss out of proportion to her retinal findings.

RESULTS: The patient was found to have cat scratch disease by antibody titers.

CONCLUSION: Cat scratch disease should be considered in patients with a serous neurosensory retinal detachment of the macula and a history of cat exposure or systemic signs or symptoms consistent with the disease. 

=========================================================================
22.) Cat scratch disease in Greece. 
=========================================================================
Author 
Karpathios T; Golphinos C; Psychou P; Garoufi A; Papadimitriou A; Nicolaidou P 
Address 
Second Department of Paediatrics, P and A Kyriakou Children's Hospital, Athens, Greece. 
Source 
Arch Dis Child, 78(1):64-6 1998 Jan 

Abstract 

An indirect fluorescent antibody test for Bartonella henselae, B quintana, and B elizabethae was performed in all 18 children who presented to our paediatric outpatient clinic with cat scratch disease over a six year period. Serum samples were taken on admission, after 15 days, and after six months. Diagnosis was confirmed in 15 patients (83%) and was based on seroconversion or a fourfold change of the antibody titre to B henselae in 12 patients and on a single high titre (> 128) in three patients.

Lymphadenopathy was present in all patients, erythema nodosum in one, osteomyelitis in one, hepatitis in one, transverse myelitis in one, and liver or spleen granulomata, or both, in three patients.

Cat scratch disease developed in autumn or winter in 12 patients. All had a history of physical contact with a cat. Our study shows that our clinical suspicion was accurate in the diagnosis of cat scratch disease in a high percentage of patients presenting to a hospital and that indirect fluorescent antibody testing for B henselae is a useful diagnostic tool. 

=========================================================================
23.) Cat-scratch disease--an overlooked disease in Denmark?]
=========================================================================
Kattekradssygdom--en overset sygdom i Danmark? Blomgren M; Hardt-Madsen M Organkirurgisk afdeling K, Sygehus Fyn.
Ugeskr Laeger (DENMARK) May 5 1997 159 (19) p2876-7 ISSN: 0041-5782
Language: DANISH Summary Language: ENGLISH
Document Type: 
JOURNAL ARTICLE English Abstract
Journal Announcement: 9708

Subfile: INDEX MEDICUS

Only one patient with cat-scratch disease (CSD) has been reported in Denmark. A  case and retrospective investigation among patients admitted to the ward is presented.  Over a period of 3.5 years, six patients were found to have suffered from CSD. The  yearly incidence was calculated to 2.6/100,000.

The patients were tested for  antibodies against Bartonella (Rochalimaea) henselae with a new test developed at the  Danish Serum Institute. Only two of the patients with CSD had titres of antibodies  higher than 400 (positive). Tested again with an improved test five of the six  patients were found to have antibodies against B. henselae. It is assumed that CSD  is found with the same incidence as the USA and Holland.

 It is recommended that  examination for chronic lymphadenopathy includes questions about cat contact and  testing for antibodies against Bartonella henselae.

=========================================================================
24.) Prolonged Bartonella bacteremia in cats associated with cat-scratch disease patients. 
=========================================================================
Author 
Kordick DL; Wilson KH; Sexton DJ; Hadfield TL; Berkhoff HA; Breitschwerdt EB 
Address 
Department of Companion Animal and Special Species Medicine, College of Veterinary Medicine, North Carolina State University, Raleigh 27606, USA. 
Source 
J Clin Microbiol, 33(12):3245-51 1995 Dec 

Abstract 

Recent evidence supports a causal relationship between Bartonella (Rochalimaea) henselae, cat-scratch disease (CSD), and bacillary angiomatosis. Cats appear to be the primary reservoir. Blood from 19 cats owned by 14 patients diagnosed with CSD was cultured. Blood samples from cats owned by veterinary students (n = 25) having no association with CSD or bacillary angiomatosis were cultured as controls. Eighty-nine percent (17 of 19) of cats associated with CSD patients and 28% (7 of 25) of controls were bacteremic with Bartonella species (chi-square = 16.47; P < 0.001).

Twenty-three isolates were characterized as B. henselae, while one isolate from the cat of a CSD patient appeared to be a new Bartonella species. Thirteen cats remained culture positive during the ensuing 12-month period. Our results support the conclusion that B. henselae is the predominant species involved in CSD and is transmitted by cats. The incidence of Bartonella bacteremia in control cats suggests that B. henselae bacteremia is prevalent among the domestic cat population in the United States. 

=========================================================================
25.) Application of polymerase chain reaction assay in the diagnosis of orbital granuloma complicating atypical oculoglandular cat scratch disease. 
=========================================================================
Author 
Dondey JC; Sullivan TJ; Robson JM; Gatto J 
Address 
Oculoplastics Clinic, Department of Ophthalmology, Royal Brisbane Hospital, Herston, Australia. 
Source 
Ophthalmology, 104(7):1174-8 1997 Jul 

Abstract 

BACKGROUND: Parinaud oculoglandular syndrome is uncommon. Most cases are caused by cat scratch disease (CSD), recently discovered to be associated with the pathogen Bartonella henselae. Before isolation of the micro-organism, diagnosis relied on the presence of characteristic clinical features. However, atypical cases could cause diagnostic problems. With the development of an indirect fluorescent antibody test and polymerase chain reaction (PCR) assay, oculoglandular CSD can be diagnosed readily.

METHODS: The authors report a case of atypical Parinaud oculoglandular syndrome in a 51-year-old woman who presented with an inferior conjunctival forniceal mass extending into anterior orbital tissues. Blood and operative tissue specimens were obtained for routine screening and histopathologic analysis but more specifically for serologic analysis, culture, and PCR assay for B. henselae. Computed tomography was performed to delineate the mass.

RESULTS: Cultures for B. henselae were negative. Initial serologic analysis demonstrated a low IgG response without detectable IgM, but 1 month later had undergone a fourfold rise in IgG, again without detectable IgM. Histopathologic analysis showed a nonspecific necrotizing granulomatous inflammation consistent with but not diagnostic of CSD. Polymerase chain reaction assay for B. henselae was strongly positive. Computed tomographic scan showed a preseptal and anterior orbital inflammatory process.

CONCLUSIONS: Cat scratch disease due to B. henselae should be suspected in patients with atypical conjunctival inflammation associated with regional lymphadenopathy. PCR assay is extremely useful in establishing the diagnosis. The PCR assay offers the additional advantage of early diagnosis because the test is positive early in the disease. Antibiotic therapy remains controversial. In this case, surgical excision hastened resolution of the conjunctival inflammation. However, the lymphadenopathy responded poorly to antibiotics. 

=========================================================================
26.) Systemic cat scratch disease: hepatic and splenic involvement about 3 pediatric cases. 
=========================================================================
Author 
Destuynder O; Vanlemmans P; Mboyo A; Destuynder R; Aubert D; DeBilly B; Colin P; Leroy J; Estavoyer JM; Viennet G 
Address 
Department of Pediatric Surgery, Saint-Jacques Hospital Besan¸con, France. 
Source 
Eur J Pediatr Surg, 5(6):365-8 1995 Dec 

Abstract 

Numerous diseases can lead to multinodular lesions of liver and spleen; surgical biopsy can be required for the etiologic diagnosis. Among these diseases, systemic cat scratch disease has been recently described. Macroscopical appearance of the lesions is evocative and must be known by surgeons. Three children with systemic cat scratch disease involving liver and spleen are reported. 

=========================================================================
27.) Bartonella clarridgeiae, a newly recognized zoonotic pathogen causing inoculation papules, fever, and lymphadenopathy (cat scratch disease). 
=========================================================================
Author 
Kordick DL; Hilyard EJ; Hadfield TL; Wilson KH; Steigerwalt AG; Brenner DJ; Breitschwerdt EB 
Address 
Department of Companion Animal and Special Species Medicine, College of Veterinary Medicine, North Carolina State University, Raleigh 27606, USA. 
Source 
J Clin Microbiol, 35(7):1813-8 1997 Jul 

Abstract 

Shortly after adopting a 6-week-old cat, a veterinarian was bitten on the left index finger. Within 3 weeks, he developed headache, fever, and left axillary lymphadenopathy. Initial blood cultures from the cat and veterinarian were sterile. Repeat cultures from the cat grew Bartonella-like organisms with lophotrichous flagella. Sera from the veterinarian were not reactive against Bartonella henselae, B. quintana, or B. elizabethae antigens but were seroreactive (reciprocal titer, 1,024) against the feline isolate.

Sequential serum samples from the cat were reactive against antigens of B. henselae (titer, 1,024), B. quintana (titer, 128), and the feline isolate (titer, 2,048). Phenotypic and genotypic characterization of this and six additional feline isolates, including microscopic evaluation, biochemical analysis, 16S rRNA gene sequencing, DNA-DNA hybridization, and PCR-restriction fragment length polymorphism of the 16S gene, 16S-23S intergenic spacer region, and citrate synthase gene identified the isolates as B. clarridgeiae.

This is the first report of cat scratch disease associated with B. clarridgeiae. 

=========================================================================
28.) Coinfection with Bartonella clarridgeiae and Bartonella henselae and with different Bartonella henselae strains in domestic cats.
=========================================================================
Gurfield AN; Boulouis HJ; Chomel BB; Heller R; Kasten RW; Yamamoto K; Piemont Y
Department of Population Health and Reproduction, School of Veterinary Medicine,  University of California, Davis, 95616, USA.
J Clin Microbiol (UNITED STATES) Aug 1997 35 (8) p2120-3 ISSN: 0095-1137
Language: ENGLISH
Document Type: JOURNAL ARTICLE 
Journal Announcement: 9711

Subfile: INDEX MEDICUS

Bartonella clarridgeiae and several strains of Bartonella henselae, the agent of  cat scratch disease, with variations in the 16S rRNA gene have been found to infect  the blood of cats. An epidemiologic study of Bartonella infection in domestic French  cats revealed that of 436 cats sampled, 5 cats (1.1%) were coinfected with B.  henselae and B. clarridgeiae and 2 cats (0.5%) were coinfected with two strains of B.  henselae with variations in the 16S rRNA gene, B. henselae type I and type II.

In an  indirect immunofluorescence assay, coinfected cats tested positive for both  Bartonella species at titers of > or = 128. Identification of the colonies was  achieved by preformed enzyme analysis, PCR-restriction fragment length polymorphism  analysis of the citrate synthase gene, and 16S rRNA gene sequencing. Colony size  differences in mixed culture allowed differentiation of the Bartonella species. The  coinfection of cats with two Bartonella species or variants of the same species  raises concern about the possibility of dual infection in humans. The development of  a polyvalent vaccine targeted against the most pathogenic or invasive strains may be  a means of protecting cats and man from infection.

=========================================================================
29.) [Cat-scratch disease: historical, clinical, phylogenetic and taxonomic aspects] Katzenkratzkrankheit: historische, klinische, phylogenetische und taxonomische 
Aspekte.
=========================================================================
Muller HE
Tierarztl Prax (GERMANY) Apr 1997 25 (2) p94-9 ISSN: 0303-6286
Language: GERMAN Summary Language: ENGLISH
Document Type: 
JOURNAL ARTICLE; REVIEW; REVIEW, TUTORIAL English Abstract
Journal Announcement: 9708

Subfile: INDEX MEDICUS

The cat-scratch disease (CSD) is known as a nosological entity since 1950. It was  diagnosed by the clinical symptoms, epidemiologic data, and the intracutaneous test  of Hanger and Rose. The aetiologic agent is Bartonella (formerly Rochalimaea)  henselae occurring in thirty to fifty percent of healthy cats. The gramnegative  alpha-2-proteobacteria cause the CSD but also fever in healthy humans. Patients  suffering from AIDS show bacillary angiomatosis, bacillary peliosis hepatis,  endocarditis, and septicemia.

There is an open question for other aetiologic agents  causing CSD as cofactors. For example, Afipia felis is found to a certain extent  from patients suffering from CSD. Furthermore, Rothia dentocariosa was isolated in  lymphnodes of CSD patients, and also other grampositive rods may play an important  role together with B. henselae in CSD. (30 References)

=========================================================================
30.) Molecular diagnosis of cat scratch disease: a two-step approach.
=========================================================================
Avidor B; Kletter Y; Abulafia S; Golan Y; Ephros M; Giladi M
The Bernard Pridan Laboratory for Molecular Biology of Infectious Diseases, Ichilov 
Hospital, Tel-Aviv Sourasky Medical Center, Israel.
J Clin Microbiol (UNITED STATES) Aug 1997 35 (8) p1924-30 ISSN:
0095-1137
Language: ENGLISH
Document Type: JOURNAL ARTICLE 
Journal Announcement: 9711

Subfile: INDEX MEDICUS

Amplification of Bartonella henselae DNA has been proposed as a diagnostic test for  cat scratch disease (CSD). The sensitivities of the following three PCR assays were  compared. PCR/rRNA with universal primers amplifies part of the 16S rRNA gene,  followed by hybridization with a specific B. henselae probe; PCR/CS and PCR/HSP  amplify portions of the gltA and the htrA genes, respectively, each followed by  restriction fragment length polymorphism analysis. The threshold of detection of B.  henselae DNA in pus was 10(-4), 10(-3), and 10(-2) ng for PCR/rRNA, PCR/CS, and  PCR/HSP, respectively. By these three assays, B. henselae DNA was detected in 100,  94, and 69% of 32 pus and lymph node specimens from CSD patients, respectively.

The  similar sensitivities of the PCR/rRNA and the PCR/CS assays for detecting B. henselae  DNA in clinical specimens are in contrast to the 10-fold difference in sensitivities  in favor of PCR/rRNA demonstrated with purified B. henselae DNA in sterile pus,  suggesting that in the majority of cases, the bacterial load in clinical specimens is  large enough to be identified by the PCR/CS assay. A two-step approach is suggested  to achieve maximal sensitivity for detecting B. henselae in clinical specimens:  initial testing by PCR/CS (which does not require hybridization), followed by  PCR/rRNA with PCR/CS-negative specimens when CSD is strongly suspected.

=========================================================================
31.) Antibiotic therapy for cat-scratch disease: clinical study of therapeutic outcome in 268 patients and a review of the literature.
=========================================================================
Author(s) Margileth AM
Address Department of Pediatrics, University of Virginia Health Sciences Center, Charlottesville.
Source Pediatr Infect Dis J 1992;11:474.

Abstract 

During 24 months in an uncontrolled, retrospective study of 268 patients with cat-scratch disease (CSD), 202 were treated with 18 different antimicrobial agents. Criteria for antibiotic effectiveness were established. One or two antibiotics were taken separately for at least 3 to 5 days by 202 patients with CSD.

Outcome was determined by follow-up examinations and telephone. Effectiveness of antibiotic therapy was based upon 3 or more days of therapy and clinical improvement of the patient with absence of and/or a decrease in malaise, fatigue, fever, headache, anorexia, lymphadenopathy and, in 90 patients, a declining or normal sedimentation rate. Of 18 different antimicrobials prescribed, 14 commonly used antibiotics were judged to be of little or no value in treatment of CSD. Four antimicrobials were efficacious. Efficacy of the three oral drugs in decreasing order was: rifampin 87%, ciprofloxacin 84%, trimethoprim-sulfamethoxazole 58%. Gentamicin sulfate intramuscular was 73% effective. Antibiotic therapy can be considered for patients with severe cat scratch disease. Conservative, symptomatic treatment is recommended for the majority of patients with mild or moderate CSD.

=========================================================================
32.) Successful treatment of cat-scratch disease with ciprofloxacin [see comments]
=========================================================================
Author(s) Holley HP Jr
Address Division of Infectious Diseases, Medical University of South Carolina, Charleston 29425.
Source JAMA 1991;265:1563 - 5.

Abstract 

Cat-scratch disease is usually a benign, self-limited disease. Infection may be asymptomatic but is commonly associated with painful regional lymphadenitis. Occasionally, disease may result in systemic symptoms and dissemination. Five adult patients, aged 24 to 57 years, were diagnosed as having cat-scratch disease, based on a positive history of cat scratches followed by typical symptoms including painful regional lymphadenitis, malaise, and positive cat-scratch skin tests.

Diagnostic evaluations revealed no other cause for the lymphadenitis. Three patients had not received prior treatment with antibiotics, and two patients had failed to improve on other antibiotics. All five were treated with oral ciprofloxacin, 500 mg by mouth, twice daily. All patients had dramatic improvement in symptoms within a few days and none has relapsed during follow-up.

This is the first report of successful treatment of cat-scratch disease with ciprofloxacin, which appears to be an effective therapy for cat-scratch disease in adults.

=========================================================
33.) Diverse Clinical Signs of Ocular Involvement in Cat Scratch Disease.
========================================================

Turk J Ophthalmol. 2017 Jan;47(1):9-17. doi: 10.4274/tjo.28009. Epub 2017 Jan 17.
Oray M1, Önal S2, Koç Akbay A3, Tuğal Tutkun İ1.
Author information
1İstanbul University İstanbul Faculty of Medicine, Department of Ophthalmology, İstanbul, Turkey.
2Koç University Faculty of Medicine, Department of Ophthalmology; VKV American Hospital, Ophthalmology Clinic, İstanbul, Turkey.
3Koç University Faculty of Medicine, Department of Ophthalmology, İstanbul, Turkey.
Abstract
OBJECTIVES:
To describe ocular manifestations, diagnosis, and treatment of cat scratch disease.
MATERIALS AND METHODS:
Clinical records of patients with ocular cat scratch disease were reviewed.
RESULTS:
Thirteen eyes of 10 patients (7 female, 3 male) with a mean age of 26.9±18.5 years were included. Nine patients had a history of cat contact and had systemic symptoms associated with cat scratch disease 2-90 days prior to the ocular symptoms. Ocular signs were: neuroretinitis in 4 eyes (associated with serous retinal detachment in the inferior quadrant in 1 eye), optic neuropathy in 2 eyes (1 papillitis and optic disc infiltration, 1 optic neuritis), retinal infiltrates in 6 eyes, retinochoroiditis in 1 eye, branch retinal arteriolar occlusion in 3 eyes, and endophthalmitis in 1 eye. Visual acuities at presentation were 1.0 in 7 eyes, 0.3 in 1 eye, ≤0.1 in 4 eyes, and light perception in 1 eye. Bartonella henselae immunoglobulin (Ig) M and/or IgG were positive in all patients. Systemic antibiotic therapy was administered in all patients. Systemic corticosteroid treatment (15-40 mg/day) was added to the therapy in 4 patients, following 5 days of intravenous pulse methylprednisolone in 2 patients. Treatment was ongoing for 1 patient and the mean treatment duration of the other 9 patients was 47±14.5 days. Visual acuities at final visit were 1.0 in 9 eyes, 0.8 in 1 eye, 0.4 in 1 eye, and no light perception in 1 eye.
CONCLUSION:
Cat scratch disease may present with different ocular signs and should be considered in the differential diagnosis in patients with such presentations.

=================================================================
34.) Cat Scratch Disease: Expanded Spectrum.
===============================================

Ocul Oncol Pathol. 2016 Oct;2(4):246-250. Epub 2016 Jul 1.
Aziz HA1, Plesec TP2, Sabella C3, Udayasankar UK4, Singh AD1.
Author information
1Department of Ophthalmology, Cole Eye Institute, Ohio, USA.
2Anatomic Pathology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
3Pediatric Infectious Diseases, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
4Radiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Abstract
BACKGROUND:
To expand the spectrum of ophthalmic manifestations in cat scratch disease.
METHODS:
Case report.
RESULTS:
A 7-year-old male was referred for evaluation of his left optic disc after failing vision screening test at school. His visual acuity was 20/20 OD and light perception OS. Fundus examination showed a left optic disc lesion associated with an exudative retinal detachment and vitreous seeding. Ultrasonography revealed a 7 × 7.5 × 3.8 mm lesion with a possible 6.3 mm of retrolaminar extension into the substance of the optic nerve. Brain MRI did not show evidence of optic nerve involvement but revealed a 6-mm nodule of the pineal gland suggestive of a pineoblastoma. Enucleation was performed and histopathology revealed a suppurative granulomatous inflammation suggestive of Bartonella infection. Upon further questioning, the patient had recent exposure to kittens with areas of cat scratches along both of his arms. He was subsequently referred to and treated with a 2-week course of trimethoprim-sulfamethoxazole and rifampin by the pediatric infectious disease specialist. Repeat brain MRI showed interval total resolution of enlarged pineal gland. Conclusion: Optic nerve granulomas are a rare presentation of cat scratch disease and could potentially masquerade as retinoblastoma.

============================================
35.) Dynamics of Co-Infection with Bartonella henselae Genotypes I and II in Naturally Infected Cats: Implications for Feline Vaccine Development.
=======================================================

Microb Ecol. 2017 Feb 2. doi: 10.1007/s00248-017-0936-8. [Epub ahead of print]
Huwyler C1,2, Heiniger N1,2, Chomel BB3, Kim M1,2, Kasten RW3, Koehler JE4,5.
Author information
1Microbial Pathogenesis and Host Defense Program, University of California, San Francisco, San Francisco, CA, 94143-0654, USA.
2Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, 513 Parnassus Ave., Room S-380, San Francisco, CA, 94143-0654, USA.
3Department of Population Health and Reproduction, School of Veterinary Medicine, University of California, Davis, CA, 95616, USA.
4Microbial Pathogenesis and Host Defense Program, University of California, San Francisco, San Francisco, CA, 94143-0654, USA. jkoehler@medicine.ucsf.edu.
5Department of Medicine, Division of Infectious Diseases, University of California, San Francisco, 513 Parnassus Ave., Room S-380, San Francisco, CA, 94143-0654, USA. jkoehler@medicine.ucsf.edu.
Abstract
Bartonella henselae is an emerging bacterial pathogen causing cat-scratch disease and potentially fatal bacillary angiomatosis in humans. Bacteremic cats constitute a large reservoir for human infection. Although feline vaccination is a potential strategy to prevent human infection, selection of appropriate B. henselae strains is critical for successful vaccine development. Two distinct genotypes of B. henselae (type I, type II) have been identified and are known to co-infect the feline host, but very little is known about the interaction of these two genotypes during co-infection in vivo. To study the in vivo dynamics of type I and type II co-infection, we evaluated three kittens that were naturally flea-infected with both B. henselae type I and type II. Fifty individual bloodstream isolates from each of the cats over multiple time points were molecularly typed (by 16S rRNA gene sequencing), to determine the prevalence of the two genotypes over 2 years of persistent infection. We found that both B. henselae genotypes were transmitted simultaneously to each cat via natural flea infestation, resulting in mixed infection with both genotypes. Although the initial infection was predominately type I, after the first 2 months, the isolated genotype shifted to exclusively type II, which then persisted with a relapsing pattern. Understanding the parameters of protection against both genotypes of B. henselae, and the competitive dynamics in vivo between the two genotypes, will be critical in the development of a successful feline vaccine that can ultimately prevent B. henselae transmission to human contacts.

================================================================
36.) Bacillary angiomatosis with bone invasion.
================================================================

An Bras Dermatol. 2016 Nov-Dec;91(6):811-814. doi: 10.1590/abd1806-4841.20165436.
Diniz LM1, Medeiros KB1, Landeiro LG1, Lucas EA1.
Author information
1Universidade Federal do Espírito Santo (UFES) - Vitória (ES), Brazil.
Abstract
Bacillary angiomatosis is an infection determined by Bartonella henselae and B. quintana, rare and prevalent in patients with acquired immunodeficiency syndrome. We describe a case of a patient with AIDS and TCD4+ cells equal to 9/mm3, showing reddish-violet papular and nodular lesions, disseminated over the skin, most on the back of the right hand and third finger, with osteolysis of the distal phalanx observed by radiography. The findings of vascular proliferation with presence of bacilli, on the histopathological examination of the skin and bone lesions, led to the diagnosis of bacillary angiomatosis. Corroborating the literature, in the present case the infection affected a young man (29 years old) with advanced immunosuppression and clinical and histological lesions compatible with the diagnosis.

==========================================================
37.) Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis.
==========================================================

N Engl J Med. 1997 Dec 25;337(26):1876-83.
Koehler JE1, Sanchez MA, Garrido CS, Whitfeld MJ, Chen FM, Berger TG, Rodriguez-Barradas MC, LeBoit PE, Tappero JW.
Author information
1Department of Medicine, University of California, San Francisco 94143-0654, USA.
Abstract
BACKGROUND:
Bacillary angiomatosis and bacillary peliosis are vascular proliferative manifestations of infection with species of the genus bartonella that occur predominantly in patients infected with the human immunodeficiency virus. Two species, B. henselae and B. quintana, have been associated with bacillary angiomatosis, but culture and speciation are difficult, and there has been little systematic evaluation of the species-specific disease characteristics. We studied 49 patients seen over eight years who were infected with bartonella species identified by molecular techniques and who had clinical lesions consistent with bacillary angiomatosis-peliosis.
METHODS:
In this case-control study, a standardized questionnaire about exposures was administered to patients with bacillary angiomatosis-peliosis and to 96 matched controls. The infecting bartonella species were determined by molecular techniques.
RESULTS:
Of the 49 patients with bacillary angiomatosis-peliosis, 26 (53 percent) were infected with B. henselae and 23 (47 percent) with B. quintana. Subcutaneous and lytic bone lesions were strongly associated with B. quintana, whereas peliosis hepatis was associated exclusively with B. henselae. Patients with B. henselae infection were identified throughout the study period and were epidemiologically linked to cat and flea exposure (P< or =0.004), whereas those with B. quintana were clustered and were characterized by low income (P=0.003), homelessness (P = 0.004), and exposure to lice (P= 0.03). Prior treatment with macrolide antibiotics appeared to be protective against infection with either species.
CONCLUSIONS:
B. henselae and B. quintana, the organisms that cause bacillary angiomatosis-peliosis, are associated with different epidemiologic risk factors and with predilections for involvement of different organs.

=================================================================
38.) Corticosteroid Treatment for Prolonged Fever in Hepatosplenic Cat-Scratch Disease.
============================================================

Clin Pediatr (Phila). 2016 Dec 1:9922816684606. doi: 10.1177/0009922816684606. [Epub ahead of print]
Phan A1,2, Castagnini LA1,2.
Author information
11 Baylor College of Medicine, San Antonio, TX, USA.
22 The Children's Hospital of San Antonio, San Antonio, TX, USA.
Abstract
Hepatosplenic cat-scratch disease (CSD) may cause prolonged fever. We present the case of a 4-year-old boy with confirmed hepatosplenic CSD with fever lasting 3 months despite use of multiple different antimicrobial agents. The patient became afebrile soon after corticosteroid therapy was started. Our case indicates corticosteroids may be useful in patients with hepatosplenic CSD and prolonged fever.

=================================================================
39.) Final Diagnosis in Patients Referred with a Diagnosis of Neuroretinitis.
================================================================

Neuroophthalmology. 2015 Dec 14;39(6):266-270. eCollection 2015.
Kahloun R1, Khairallah-Ksiaa I1, Abroug N1, Mahmoud A1, Ben Yahia S1, Zaouali S1, Jelliti B1, Khairallah M1.
Author information
Abstract
The purpose of this study was to determine final diagnosis of patients referred with a diagnosis of neuroretinitis. A retrospective study of 40 patients with optic disc oedema with macular star (ODOMS) referred with a diagnosis of neuroretinitis was conducted. The final diagnosis was neuroretinitis in 26 patients (65%), with most of these patients (96.1%) having unilateral involvement. Main underlying aetiologies included cat scratch disease (30.8%), rickettsiosis (19.2%), and idiopathic neuroretinitis (23.1%). The remaining 14 patients (35%) had ODOMS that had been mistaken for neuroretinitis. Of these patients, 42.8% were found to have a previously unknown malignant systemic hypertension in association with bilateral ODOMS. Neuroretinitis, usually unilateral, should be differentiated from other causes of unilateral or most often bilateral ODOMS that may masquerade as neuroretinitis, mainly malignant systemic hypertension. This is essential to avoid inappropriate work-up and management and subsequent potential visual or systemic morbidity.

=================================================================
40.) Disseminated cat-scratch disease: case report and review of the literature.
================================================================

Paediatr Int Child Health. 2016 Jan 12:1-3. [Epub ahead of print]
Chang CC1, Lee CJ2, Ou LS3, Wang CJ1, Huang YC2,4.
Author information
Abstract
Cat scratch disease (CSD) can present as a systemic disease in 5-10% of cases and lead to various disease entities. A previously healthy 16-month-old boy presented with fever for 7 days without other obvious symptoms. Abdominal computed tomography scan demonstrated enlarged right inguinal lymph nodes and multiple small round hypodensities in the spleen. Despite antibiotic treatment for 1 week, the fever persisted and the intrasplenic lesions progressed. Inguinal lymph node biopsy confirmed CSD by immunohistochemistry staining. The diagnosis of CSD was also supported by a history of contact, imaging and serological findings. The patient recovered after treatment with azithromycin for a total of 5 weeks and, in serial follow-up, the hepatosplenic micro-abscesses resolved after 4th months.

========================================================
41.) Multiple Renal and Splenic Lesions in Cat Scratch Disease.

========================================================

Jpn J Infect Dis. 2016 Sep 21;69(5):424-5. doi: 10.7883/yoken.JJID.2015.362. Epub 2015 Nov 13.
Wakiguchi H1, Okamoto Y, Matsunaga M, Kodama Y, Miyazono A, Seki S, Ikeda N, Kawano Y.
Author information
1Department of Pediatrics, Kagoshima University Graduate School of Medical and Dental Sciences.
Abstract
Cat scratch disease (CSD) is an infectious disease caused by Bartonella henselae. Atypical clinical presentations of CSD include prolonged fever and multiple hepatosplenic lesions. Furthermore, multiple renal lesions are extremely rare in CSD. An 11-year-old Japanese girl presented at our hospital with a prolonged fever of unknown cause after being scratched and bitten by a kitten. Abdominal computed tomography (CT) revealed multiple small, round hypodense lesions in both kidneys and the spleen. Based on her history and the CT results, her diagnosis was CSD. The diagnosis was confirmed by serological tests, which indicated antibodies against B. henselae. After treatment with azithromycin, her fever immediately improved. Careful history taking and imaging are essential for the diagnosis of atypical CSD. In CT images, not only hepatosplenic lesions but also renal lesions are important features indicative of a diagnosis of atypical CSD. Subsequently, a diagnosis of CSD can be confirmed by specific serological tests. This is the first reported Japanese case of multiple renal and splenic lesions in a patient with CSD. Although difficult to diagnose, an early diagnosis atypical CSD and appropriate treatment are important to prevent complications and the need for invasive examinations.

================================================================
=====================================================
42.) Cat-Scratch Disease in the United States, 2005-2013.
======================================================

Emerg Infect Dis. 2016 Oct;22(10):1741-6. doi: 10.3201/eid2210.160115.
Nelson CA, Saha S, Mead PS.
Abstract
Cat-scratch disease (CSD) is mostly preventable. More information about the epidemiology and extent of CSD would help direct prevention efforts to those at highest risk. To gain such information, we reviewed the 2005-2013 MarketScan national health insurance claims databases and identified patients <65 years of age with an inpatient admission or outpatient visit that included a CSD code from the International Classification of Diseases, Ninth Revision, Clinical Modification. Incidence of CSD was highest among those who lived in the southern United States (6.4 cases/100,000 population) and among children 5-9 years of age (9.4 cases/100,000 population). Inpatients were significantly more likely than outpatients to be male and 50-64 years of age. We estimate that each year, 12,000 outpatients are given a CSD diagnosis and 500 inpatients are hospitalized for CSD. Prevention measures (e.g., flea control for cats) are particularly helpful in southern states and in households with children. ==================================================================

43.) Cat fleas (Ctenocephalides felis) from cats and dogs in New Zealand: Molecular characterisation, presence of Rickettsia felis and Bartonella clarridgeiae and comparison with Australia.
===============================================================

Vet Parasitol. 2017 Jan 30;234:25-30. doi: 10.1016/j.vetpar.2016.12.017. Epub 2016 Dec 28.
Chandra S1, Forsyth M2, Lawrence AL3, Emery D1, Šlapeta J4.
Author information
1School of Life and Environmental Sciences, Faculty of Veterinary Science, University of Sydney, NSW, Australia.
2Merial New Zealand, Auckland, New Zealand.
3School of Life and Environmental Sciences, Faculty of Veterinary Science, University of Sydney, NSW, Australia; Department of Medical Entomology, The University of Sydney and Pathology West, ICPMR, Westmead Hospital, Westmead, NSW, Australia.
4School of Life and Environmental Sciences, Faculty of Veterinary Science, University of Sydney, NSW, Australia. Electronic address: jan.slapeta@sydney.edu.au.
Abstract
The cat flea (Ctenocephalides felis) is the most common flea species parasitising both domestic cats and dogs globally. Fleas are known vectors of zoonotic pathogens such as vector borne Rickettsia and Bartonella. This study compared cat fleas from domestic cats and dogs in New Zealand's North and South Islands to Australian cat fleas, using the mitochondrial DNA (mtDNA) marker, cytochrome c oxidase subunit I and II (cox1, cox2). We assessed the prevalence of Rickettsia and Bartonella using genus specific multiplexed real-time PCR assays. Morphological identification confirmed that the cat flea (C. felis) is the most common flea in New Zealand. The examined fleas (n=43) at cox1 locus revealed six closely related C. felis haplotypes (inter-haplotype distance 1.1%) across New Zealand. The New Zealand C. felis haplotypes were identical or near identical with haplotypes from southern Australia demonstrating common dispersal of haplotype lineage across both the geographical (Tasman Sea) and climate scale. New Zealand cat fleas carried Rickettsia felis (5.3%) and Bartonella clarridgeiae (18.4%). To understand the capability of C. felis to vector zoonotic pathogens, we determined flea cox1 and cox2 haplotype diversity with the tandem multiplexed real-time PCR and sequencing for Bartonella and Rickettsia. This enabled us to demonstrate highly similar cat fleas on cat and dog populations across Australia and New Zealand.
   ==================================================================

 

  Produced by Dr. Jose Lapenta R. Dermatologist

                 Maracay Estado Aragua Venezuela 2.025

           Telf: 04142976087 - 04127766810   


                                                         

Si Te ha gustado, Compartelo

No hay comentarios:

Publicar un comentario

Tu comentario será objeto de revisión y luego aprobado.
Your comment will be revised and then approved.